- Report
- April 2023
- 147 Pages
Global
From €4464EUR$4,949USD£3,827GBP
- Report
- March 2024
- 128 Pages
Global
From €3833EUR$4,250USD£3,287GBP
- Report
- June 2025
- 148 Pages
Global
From €3563EUR$3,950USD£3,055GBP
- Report
- April 2024
- 120 Pages
Global
From €3833EUR$4,250USD£3,287GBP
- Report
- March 2026
- 150 Pages
Germany
From €4374EUR$4,850USD£3,751GBP
- Report
- March 2026
- 150 Pages
Canada
From €4374EUR$4,850USD£3,751GBP
- Report
- March 2026
- 150 Pages
India
From €4374EUR$4,850USD£3,751GBP
- Report
- March 2026
- 150 Pages
China
From €4374EUR$4,850USD£3,751GBP
From €4059EUR$4,500USD£3,480GBP
- Report
- August 2024
- 95 Pages
Global
From €3500EUR$4,157USD£3,106GBP

The Tissue Transplant market is a subset of the biotechnology industry that focuses on the transfer of tissue from one organism to another. This process is used to treat a variety of medical conditions, including organ failure, cancer, and genetic disorders. Tissue transplants can be autologous, meaning the tissue is taken from the same individual, or allogeneic, meaning the tissue is taken from a donor. The tissue is typically processed and stored in a laboratory before being transplanted.
The tissue transplant market is driven by advances in biotechnology, such as gene editing and stem cell research. These technologies have enabled the development of new treatments and therapies, as well as improved safety and efficacy of existing treatments. Additionally, the increasing prevalence of chronic diseases has led to an increased demand for tissue transplants.
Notable companies in the tissue transplant market include Organogenesis, Histogenics, and Osiris Therapeutics. These companies specialize in the development and commercialization of tissue transplant products and services. Show Less Read more